Erythropoietin in patients with head and neck carcinomas?;Erythropoietin bei karzinomen im kopf-/halsbereich?

Laryngo- Rhino- Otologie

Volumn 83, Issue 5, 2004, Pages 292-297

  Schipper, J ^a   Henke, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Pretherapeutical hemoglobin value; Prognosis; Progression; Prospective placebo controlled double blind study

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEAD AND NECK CARCINOMA; HEAD CANCER; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; NECK CANCER; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ANEMIA; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINOMETRY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PREMEDICATION; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT;

EID: 2942753749     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814310     Document Type: Article

References (46)

1. Grau C, Overgaard J. Significance of hemoglobin concentration for treatment outcome Berlin, Heidelberg, New York: Springer, 2000: 101-111
2. Henke M, Momm F, Guttenberger R. Erythropoietin for patients undergoing radiotherapy: The Freiburg experience Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1999: 91-97
3. Becker A, Stadler P, Lavey RS, Hansgen G, Kuhnt T, Lautenschlager C, Feldmann HJ, Molls M, Dunst J. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2000; 46 (2): 459-466
4. Hall EJ. The oxygen effect and reoxygenation in radiobiology for the radiologist, 3 ed. Philadelphia: Lipincott, 1988: 137-160
5. Gray LH, Conger AD, Ebert M. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953; 26 (312): 26638-26648
6. Lutterbach J, Guttenberger R. Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx. Int J Radiat Oncol Biol Phys 2000; 48 (5): 1345-1350
7. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998; 339 (21): 1506-1514
8. Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev 1994; 13 (2): 139-168
9. Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ Jr, Coia LR. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995; 13 (8): 2077-2083
10. Frommhold H, Guttenberger R, Henke M. The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience. Strahlenther Onkol 1998; 174 (Suppl): 431-434
11. Kumar P. Tumor hypoxia and anemia: impact on the efficacy of radiation therapy. Semin Hematol 2000; 37 (4 Suppl 6): 4-8
12. Lee WR, Berkey B, Marcial V, Fu KK, Cooper JS, Vikram B, Coia LR, Rotman M, Ortiz H. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998; 42 (5): 1069-1075
13. Overgaard J, Hansen HS, Jorgensen K, Hjelm Hansen M. Primary radiotherapy of larynx and pharynx carcinoma-an analysis of some factors influencing local control and survival. Int J. Radiat Oncol Biol Phys 1986; 12 (4): 515-521
14. van Acht MJ, Hermans J, Boks DE, Leer JW. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother Oncol 1992; 23 (4): 229-235
15. Bush RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 1986; 12 (11): 2047-2050
16. Evans JC, Bergsjo P. The Influence of Anemia on the Results of Radiotherapy in Carcinoma of the Cervix. Radiology 1965; 84: 709-717
17. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 1999; 340 (6): 438-447
18. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 1999; 340 (6): 438-447
19. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5 (1): 253-259
20. Shirwadkar S, Blajchman MA, Frame B, Singal DP. Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice. J Cancer Res Clin Oncol 1992; 118 (3): 176-180
21. Shirwadkar S, Blajchman MA, Frame B, Singal DP. Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice. J Cancer Res Clin Oncol 1992; 118 (3): 176-180
22. Ludwig H, Fritz E, Kotzmann H, Hocker P, Gisslinger H, Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990; 322 (24): 1693-1699
23. Oster W, Herrmann F, Gamm H, Zeile G, Lindemann A, Muller G, Brune T, Kraemer HP, Mertelsmann R. Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol 1990; 8 (6): 956-962
24. Stuben G, Thews O, Pottgen C, Knuhmann K, Vaupel P, Stuschke M. Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice. J Cancer Res Clin Oncol 2001; 127 (6): 346-350
25. Thews O, Koenig R, Kelleher DK, Kutzner J, Vaupel P. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer 1998; 78 (6): 752-756
26. Silver DF, Piver MS. Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect. Gynecol Oncol 1999; 73 (2): 280-284
27. Silver DF, Piver MS. Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect. Gynecol Oncol 1999; 73 (2): 280-284
28. Antonadou D, Cardamakis E, Sarris G, Tzigounis V, Throuvalas V. Effect of the administration of recombinant erythropoietin in patients with pelvic malignancies during radiotherapy. Radiother Oncol 1998; 48 (Suppl): 483
29. Glaser CM, Millesi W, Kornek GV, Lang S, Schull B, Watzinger F, Selzer E, Lavey RS. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 2001; 50 (3): 705-715
30. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001; 19 (11): 2865-2874
31. Dietz A, Rudat V, Conradt C, Vanselow B, Wollensack P, Staar S, Eckel H, Volling P, Schroder M, Wannenmacher M, Muller RP, Weidauer H. Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas. HNO 2000; 48 (9): 655-664
32. Rudat V, Stadler P, Becker A, Vanselow B, Dietz A, Wannenmacher M, Molls M, Dunst J, Feldmann HJ. Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer. Strahlenther Onkol 2001; 177 (9): 462-468
33. Vanselow B, Eble MJ, Rudat V, Wollensack P, Conradt C, Dietz A. Oxygenation of advanced head and neck cancer: prognostic marker for the response to primary radiochemotherapy. Otolaryngol Head Neck Surg 2000; 122 (6): 856-862
34. Vanselow B, Eble MJ, Rudat V, Wollensack P, Conradt C, Dietz A. Oxygenation of advanced head and neck cancer: prognostic marker for the response to primary radiochemotherapy. Otolaryngol Head Neck Surg 2000; 122 (6): 856-862
35. UICC. TNM classification of malignant tumours. 5 ed. New York: John Willey & Sons, 1997
36. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991; 117 (6): 601-605
37. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991; 117 (6): 601-605
38. Cox DR. Regression models and life table (with discussion). J Royal Stat Soc B 1972; 34: 187-220
39. Henke M, Laszig R, Rübe C, Schafer V, Haase KD, Schilcher B, Mose S, Beer KT, Burger V et al. Eritropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003; 362 (9392): 1255-1260
40. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338 (25): 1798-804
41. Yu L, Vikram B, Malamud S, Yudelman I, Nussbaum M, Beattie E. Chemotherapy rapidly alternating with twice-a-day accelerated radiation therapy in carcinomas involving the hypopharynx or esophagus: an update. Cancer Invest 1995; 13 (6): 567-572
42. Di Martino E, Gagel B, Schramm O, Krombach GA, Maneschi P, Eble MJ, Westhofen M. Sonografic evaluation of oxygenation in head and neck cancer. Laryngo-Rhino-Otol 2003; 82 (11): 75-781
43. Dietz A. Prognostic factors in primary radiochemo-therapy in advanced head and neck tumours with specific reference to the tumour cell cycle components and tumour oxygenation. Laryngo-Rhino-Otol 2002; 81 (1): 63-64
44. Kehrl W, Sagowski C, Wenzel S, Metternich F, Zywietz F. Comparison between the Eppendorf histograph and the Licox system for determination oxygen partial pressure in tumor tissue. Laryngo-Rhino-Otol 2001; 80 (6): 318-323
45. Grundmann T, Jaehne M, Fritze G. The value of hyperbaric oxygen therapy (HBO) in treatment of problem wounds in the area of plastic-reconstructive head and neck surgery. Laryngo-Rhino-Otol 2000; 79 (5): 304-310
46. Jund R, Feldmann HJ, Molls M. Tissue oxygen partial pressure in human head-neck carcinomas during primary radio-chemotherapy. Laryngo-Rhino-Otol 1996; 75 (1): 43-47